Current Urology Reports

, Volume 13, Issue 6, pp 482–487 | Cite as

A Reappraisal of Storage and Voiding Dysfunction

Office Urology (N Shore, Section Editor)
First Online:

Abstract

Lower urinary tract symptoms are common in women. They may be more broadly classified into storage and voiding disorders. Recent literature has focussed on the management of voiding dysfunction and the spectrum of symptoms presented by women with such disorders. Symptoms of voiding dysfunction and storage symptoms may coexist, making diagnosis and management even more challenging. The purpose of this paper is to review the literature regarding the definition and management of voiding dysfunction with and without associated storage symptoms.

Keywords

Voiding Storage Lower urinary tract symptoms 
This is a preview of subscription content, log in to check access.

Notes

Disclosure

M Vella travel grant from Astellas Pharma; D Robinson consultant for Astellas, Ferring, Gynaecare, Uroplasty, Pfizer, Recordati; and D Staskin has received compensation as a consultant for Allergan, Astellas, American Medical Systems, Theravida, Takeda, and Uroplasty; as a lecturer for Allergan, Astellas, American Medical Systems, and Watson; and has patents (planned, pending, or issued) with American Medical Systems.

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. 1.
    Kelleher CJ, Cardozo LD, Khullar V, Salvatore S. A new questionnaire to assess the quality of life of urinary incontinent women. Br J Obstet Gynaecol. 1997;104(12):1374–9.PubMedCrossRefGoogle Scholar
  2. 2.
    Irwin DE, Milsom I, Hunskaar S, et al. Population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: results of the EPIC study. Eur Urol. 2006;50(60):1306–14.PubMedCrossRefGoogle Scholar
  3. 3.
    •• Haylen BT, de Ridder D, Freeman RM, et al. An International Urogynaecological Association (IUGA) / International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction. Int Urogynaecol J. 2010;21:5–26. This is a redefinition of all the terminology involving LUTS.CrossRefGoogle Scholar
  4. 4.
    Kupelian V, Wei J, O’Leary M, et al. Prevalence of lower urinary tract symptoms and effect on the quality of life in a racially and ethnically diverse random sample: The Boston Area Community Health (Bach) survey. Arch Intern Med. 2006;166:2381–7.PubMedCrossRefGoogle Scholar
  5. 5.
    Coyne K, Sexton C, Kopp Z, et al. The prevalence, bother, overlap of LUTS in the US, UK, Sweden: EpiLUTS. Eur Urol Suppl. 2008;7:238.CrossRefGoogle Scholar
  6. 6.
    Abrams P, Andersson KE, Birder I, et al. Fourth International Consultation on Incontinence Recommendations of the International Scientific Committee: Evaluation and treatment of urinary incontinence, pelvic organ prolapse and faecal incontinence. Neurourol Urodyn. 2010;29:213–40.PubMedCrossRefGoogle Scholar
  7. 7.
    Stoller ML, Millard RJ. The accuracy of a catheterised residual urine. J Urol. 1989;141:15–6.PubMedGoogle Scholar
  8. 8.
    Holmes JH. Ultrasonic studies of the bladder. J Urol. 1967;97:654–63.PubMedGoogle Scholar
  9. 9.
    Gehrich A, Stany MP, Fischer JR, et al. Establishing a mean post void residual in asymptomatic perimenopausal and postmenopausal women. Obstet Gynecol. 2007;110:827–32.PubMedCrossRefGoogle Scholar
  10. 10.
    • Espura-Pons M, Cardozo L, Chapple C, et al. Overactive bladder symptoms and voiding dysfunction in neurologically normal women. Neurourol Urodyn. 2012;31(4):422–8. This is very relevant to this topic.CrossRefGoogle Scholar
  11. 11.
    Fitzgerald MP, Jaffar J, Brubaker L. Risk factors for an elevated post void residual urine volume in women with symptoms of urinary urgency, frequency and urge incontinence. Int Urogynecol J Pelvic Floor Dysfunct. 2001;12:237–9.PubMedCrossRefGoogle Scholar
  12. 12.
    Milleman M, Iangenstroer P, Guralnick ML. Post-void residual urine volume in women with overactive bladder syndrome. J Urol. 2004;172:1911–4.PubMedCrossRefGoogle Scholar
  13. 13.
    Lukacz ES, DuHamel E, Menefee SA, et al. Elevated post void residual in women with pelvic floor disorders: prevalence and associated risk factors. Int Urogynaecol J. 2007;18:397–400.CrossRefGoogle Scholar
  14. 14.
    Haylen BT, Lee J, Logan V, et al. Immediate postvoid residual volumes in women with symptoms of pelvic floor dysfunction. Obstet Gynecol. 2008;111(6):1305–12.PubMedCrossRefGoogle Scholar
  15. 15.
    Groutz A, Blaivis J, Chaikin D. Bladder outlet obstruction in women: definition and characteristics. Neurourol Urodyn. 2000;19:213–20.PubMedCrossRefGoogle Scholar
  16. 16.
    Kuo HC. Videourodynamic characteristics and lower urinary tract symptoms of female bladder outlet obstruction. Urology. 2005;66:1005–9.PubMedCrossRefGoogle Scholar
  17. 17.
    Seki N, Karim OM, Mostwin JL. The effect of experimental urethral obstruction and its reversal on changes in passive electrical properties of the detrusor muscle. J Urol. 1992;148:1957–61.PubMedGoogle Scholar
  18. 18.
    Steers WD, De Groat WC. Effect of bladder outlet obstruction on micturition reflex pathway in the rat. J Urol. 1988;140:864–71.PubMedGoogle Scholar
  19. 19.
    Steers WD, Kolbeck S, Creedon D, et al. Nerve growth factor in the urinary bladder of the adult regulates neuronal form and function. J Clin Invest. 1991;88:1709–15.PubMedCrossRefGoogle Scholar
  20. 20.
    Thuroff JW, Abrams P, Andersson KE, et al. EAU guidelines on urinary incontinence. Eur Urol. 2011;59:387–400.PubMedCrossRefGoogle Scholar
  21. 21.
    Schafer W, et al. Good urodynamic practices: uroflowmetry, filling cystometry and pressure flow studies. Neurourol Urodyn. 2002;21(3):261–74.PubMedCrossRefGoogle Scholar
  22. 22.
    Nitti VW, Tu LM, Gitlin J. Diagnosing bladder outflow obstruction in women. J Urol. 1999;161:1535–40.PubMedCrossRefGoogle Scholar
  23. 23.
    Fletcher SG, Haverkorn RM, Yan J, et al. Demographic and urodynamic factors associated with persistent OAB after anterior compartment prolapse repair. Neurourol Urodyn. 2010;29:1414–8.PubMedCrossRefGoogle Scholar
  24. 24.
    Digesu GA, Salvatore S, Chahila C, et al. Do overactive bladder symptoms improve after repair of anterior vaginal wall prolapse? Int Urogynaecol J Pelvic Floor Dysfunct. 2007;18:1439–43.CrossRefGoogle Scholar
  25. 25.
    Daneshgari F, Kong W, Swartz M. Complications of midurethral slings: Important outcomes for future clinical trials. J Urol. 2008;180:1890–7.PubMedCrossRefGoogle Scholar
  26. 26.
    Huwyler M, Burton C, Renganathan A. Retrospective case modelling to assess the impact of early intervention for voiding dysfunction after retropubic tape. When is it best to intervene? Int Urogynaecol J Pelvic Floor Dysfunction. 2010;21:823–7.CrossRefGoogle Scholar
  27. 27.
    Starkman JS, Duffy JW, Wolter CE, et al. The evolution of obstruction induced overactive bladder symptoms following urethrolysis for bladder outlet obstruction. J Urol. 2008;179(3):1018–23.PubMedCrossRefGoogle Scholar
  28. 28.
    Basu M, Duckett J. The effect of urethral dilatation on pressure flow studies in women with voiding dysfunction and overactive bladder. Int Urogynaecol J Pelvic Floor Dysfunction. 2009;83:311–5.Google Scholar
  29. 29.
    Costantini E, Lazzeri M, Bini V, et al. An open label, longitudinal study of tamsulosin for functional bladder outlet obstruction in women. Urol Int. 2009;83:311–5.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2012

Authors and Affiliations

  1. 1.King’s College Hospital NHS Foundation TrustLondonUK
  2. 2.Tufts University School of MedicineBostonUSA

Personalised recommendations